[Federal Register Volume 85, Number 229 (Friday, November 27, 2020)]
[Notices]
[Page 76108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26174]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-746]
Importer of Controlled Substances Application: Noramco Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Noramco Inc. has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to Supplemental
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before December 28,
2020. Such persons may also file a written request for a hearing on the
application on or before December 28, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on October 23, 2020, Noramco Inc., 500 Swedes Landing
Road, Wilmington, Delaware, 19801-4417, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
Nabilone................................ 7379 II
Phenylacetone........................... 8501 II
Opium, Raw.............................. 9600 II
Poppy Straw Concentrate................. 9670 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to import Phenylacetone (8501), and Poppy Straw
Concentrate (9670) to bulk manufacture other controlled substances for
distribution to its customers. The company plans to import an
intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol
for distribution to its customers. In reference to drug codes 7360
(Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to
import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. No
other activity for these drug codes is authorized for this
registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-26174 Filed 11-25-20; 8:45 am]
BILLING CODE P